SAN DIEGO -– Edico Genome today announced that collaborative data generated with biochemists and geneticists from Harvard and Stanford Universities showed the DRAGEN™ Bio-IT Processor sped analysis of a whole genome sequence with 300x depth of coverage by tenfold, generating results in approximately six hours compared to 60 hours with standard software. “Processing large amounts […]
CAMBRIDGE, UK, and OMAHA, NE, USA — Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools and services that power genomics research and the development of personalized medicines, and Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology and inherited diseases through advanced diagnostic tests […]
SHANGHAI; CAMBRIDGE, Mass.; and MOUNTAIN VIEW, Calif. -– WuXi PharmaTech (Cayman) Inc. (NYSE: WX), whose leading open-access R&D capability and technology platform serves the pharmaceutical, biotechnology and medical device industries, announced today that its wholly owned subsidiary WuXi NextCODE Genomics, which provides the most proven system for using sequence data to better diagnose and treat […]
SAN DIEGO — Edico Genome, developer of the world’s first Bio-IT Processor, DRAGEN™, a solution that enables fast and cost-effective analysis of next-generation sequencing (NGS) data, today announced the United States Patent and Trademark Office has issued to the company U.S. patent number 9,014,989. This patent broadly covers proprietary processes that are core to DRAGEN, […]
Cambridge, MA and San Francisco, CA — Seven Bridges Genomics, Inc. and Station X, Inc., announced today that they have completed the integration of their respective platforms for researchers and clinicians seeking a seamless, end-to-end solution for scalable genomic data management, storage and analysis. The Seven Bridges Genomics (SBG) Platform provides an integrated environment to […]
BOSTON – Bio-IT World Conference & Expo –– SQream Technologies, provider of the world’s fastest big data analytics database, today announced the release of GenomeStack™, its latest innovative platform developed specifically for genome research. The release of GenomeStack follows last year’s general availability of SQream DB, the company’s flagship solution that introduced a high-speed GPU-based […]
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ:TBIO) today announced that its groundbreaking Multiplexed ICE COLD PCR™ (MX-ICP) technology is now available to pharmaceutical and biotechnology customers of the company’s Biomarker Identification business unit. MX-ICP is an ultra-high sensitivity DNA amplification technology that allows the detection of multiple mutations in multiple genes from any sample, either from […]
SAN DIEGO -– Edico Genome today announced a collaboration with Intel Corporation to develop solutions with Intel’s Xeon processors to accelerate next generation sequencing (NGS) data analysis. The resulting solution will enable completion of primary and secondary NGS analysis in real time, while sustaining superior accuracy, decreasing costs, streamlining data analysis in the cloud and […]
Philadelphia, PA — At Illumina APAC event in AACR 2015 meeting, Cloud Health Medical Group Ltd announced that they have already received 10 units of HiSeq X Ten System in March 2015, and launched the full service capacity of the most powerful human whole-genome sequencing platform. This will enable Cloud Health to promote the application […]
Pleasanton, CA and Redwood City, CA -— Bina Technologies, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and AstraZeneca (NYSE: AZN) today announced that they have entered into an agreement for AstraZeneca to become the first member to join the Bina Alliance Program and to further develop the Bina Genomic Management […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
